$11.5M Deal In Investor’s Off-Label Promotion Scheme Suit Gets Initial Nod
BROOKLYN, N.Y. — A federal judge in New York on Sept. 15 ruled that a proposed $11.5 million settlement between a pension fund and a biopharmaceutical company and its CEO in...To view the full article, register now.
Already a subscriber? Click here to view full article